Incretin-based therapy with glucagon-like peptide-1 (GLP-1) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors have potential lipid affects
constipation was experienced by about a quarter of patients in that group, as were diarrhea and vomiting
A doctors take For now, theres no scientific studies looking at the efficacy and safety of microdosing GLP-1s
Beyond recovery and sleep, Ipamorelin is being studied for its effects on skin health and aging, supporting improved texture, elasticity, and overall appearance
Single-particle cryo-EM studies of transmembrane proteins in SMA copolymer nanodiscs
Anecdotal reports frequently describe dramatic early responses, with multiple users noting they thought improvements were placebo on day two but by day three the changes became undeniable